MONEY

Tyra Biosciences to Host Conference Call on Interim Clinical Data of TYRA-300 from SURF301 Phase 1/2 Study on October 25, 2024, at 8am ET

Tomas Kauer - ModeratorTomas Kauer - Moderator
Oct 24, 2024 - 08:00
Tyra Biosciences to Host Conference Call on Interim Clinical Data of TYRA-300 from SURF301 Phase 1/2 Study on October 25, 2024, at 8am ET
Read More

Tags:

Previous Article

Mother sues AI chatbot company Character.AI, Google over son's suicide

Next Article

GRUPO COMERCIAL CHEDRAUI, S.A.B. DE C.V. THIRD QUARTER 2024 RESULTS

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Tomas Kauer - Moderator
Tomas Kauer - Moderator

Related Posts

HORMEL ® Ghost Reaper Chili with Beans Returns, Featuring 2 of the World's Hottest Peppers

HORMEL ® Ghost Reaper Chili with Beans Returns, Featuri...

Tomas Kauer - Mode... Oct 4, 2024

SK pharmteco Invests $260 Million to Expand Global Small Molecule and Peptide Production

SK pharmteco Invests $260 Million to Expand Global Smal...

Tomas Kauer - Mode... Sep 30, 2024

Ambetter of Illinois Expands Health Insurance Offering to 25 Counties Statewide

Ambetter of Illinois Expands Health Insurance Offering ...

Tomas Kauer - Mode... Oct 3, 2024